Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
8.29
-0.70 (-7.79%)
At close: Aug 21, 2026, 4:00 PM EDT
8.29
0.00 (0.00%)
After-hours: Aug 21, 2026, 7:57 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $3.76 billion as of August 21, 2026. Its market cap has increased by 310.17% in one year.
Market Cap
3.76B
Enterprise Value
3.50B
1-Year Change
310.17%
Ranking
Category
Stock Price
$8.29
ChartMarket Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $3.76B, an increase of 1,435.21%. That is a compound annual growth rate of 26.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 3.76B | 246.51% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 4.23B |
| Tango Therapeutics | 4.03B |
| Denali Therapeutics | 3.98B |
| Viking Therapeutics | 3.95B |
| Arcus Biosciences | 3.86B |
| IDEAYA Biosciences | 3.83B |
| Telix Pharmaceuticals | 3.80B |
| AbCellera Biologics | 3.67B |